67 results about "Dermatomyositis" patented technology

The invention discloses a colloidal gold chromatography anti-Jo-1 antibody detection test paper and a preparation method thereof. The colloidal gold chromatography anti-Jo-1 antibody detection test paper comprises a sample pad, a combination pad, a cellulose nitrate coated film and a water absorption pad, and the sample pad, the combination pad, the cellulose nitrate coated film and the water absorption pad are pasted on a base plate sequentially from one side of the base plate to the other side of the base plate, wherein the combination pad is coated with a gold-labeled antibody a and a gold-labeled antibody b; and the cellulose nitrate coated film is provided with a detection line and a quality control line, the detection line is coated with a Jo-1 antigen protein, and the quality control line is coated with a gold-labeled antibody c. By adopting indirect immunoassay to introduce the Jo-1 antigen protein in the invention to carry out process optimization on the combination pad and the sample pad, so high sensitivity, high specificity and high accuracy detection performances of the anti-Jo-1 antibody are realized, and a reference basis is provided for the auxiliary diagnosis of dermatomyositis / polymyositis.

A method of prophylactic and / or therapeutic treatment of a mammal for a disease that is caused by a Ljungan virus infection, such as Myocarditis, Cardiomyopathia, Guillain Barré Syndrome, and Diabetes Mellitus, Multiple Sclerosis, Chronic Fatigue Syndrome, Myasthenia Gravis, Amyothrophic Lateral Sclerosis, Dermatomyositis, Polymyositis, Spontaneous Abortion, Intrauterine Death, Preeclampsia, Sudden Infant Death Syndrome, Bell's (facial) paralysis, Addison's disease, and Pernicious anemia, is described. An antiviral compound effective against a Ljungan virus, such as a compound effective against a picornavirus, e.g. Pleconaril or a derivative thereof, is used for the preparation of a medicament for the treatment of a disease in a mammal that is caused by a Ljungan virus infection, to eliminate or inhibit proliferation of the virus in the mammal and at the same time prevent and / or treat the disease in the mammal. A composition for treatment of a mammal for a disease caused by Ljungan virus infection including an antiviral compound, antiserum, and an interferon. A method of treatment of a mammal for a disease caused by a Ljungan virus infection.

A method of prophylactic and / or therapeutic treatment of a mammal for a disease that is caused by a Ljungan virus infection, such as Myocarditis, Cardiomyopathia, Guillain Barré Syndrome, and Diabetes Mellitus, Multiple Sclerosis, Chronic Fatigue Syndrome, Myasthenia Gravis, Amyothrophic Lateral Sclerosis, Dermatomyositis, Polymyositis, Spontaneous Abortion, Intrauterine Death, Preeclampsia, Sudden Infant Death Syndrome, Bell's (facial) paralysis, Addison's disease, and Pernicious anemia, is described. An antiviral compound effective against a Ljungan virus, such as a compound effective against a picornavirus, e.g. Pleconaril or a derivative thereof, is used for the preparation of a medicament for the treatment of a disease in a mammal that is caused by a Ljungan virus infection, to eliminate or inhibit proliferation of the virus in the mammal and at the same time prevent and / or treat the disease in the mammal. A composition for treatment of a mammal for a disease caused by Ljungan virus infection including an antiviral compound, antiserum, and an interferon. A method of treatment of a mammal for a disease caused by a Ljungan virus infection.

The present invention relates to fatty acid analogues of the general formula R1-[xi-CH2]n—COOR2 and in particular to a method of treating inflammatory disorder selected from the group consisting of rheumatoid arthritis, systemic vasculitis, systemic lupus erythematosus, systemic sclerosis, dermatomyositis, and polymyositis; comprising administering to a mammal in need thereof, an effective amount of tetradecylthioaceticacid or tetradecylselenoacetic acid; or a pharmaceutically acceptable salt thereof.

The invention relates to traditional Chinese medicine composition for treating dermatomyositis. The traditional Chinese medicine composition comprises raw materials of traditional Chinese medicines in parts by weight as follows: 5-25 parts of donkey-hide gelatin, 5-20 parts of acanthopanax root bark, 10-30 parts of Japanese cayratia herbs, 5-20 parts of long-nosed pit viper, 5-25 parts of dodder seeds, 5-20 parts of duckweed, 2-8 parts of garden balsam, 5-25 parts of desertliving cistanche, 5-20 parts of flatstem milkvetch seeds, 10-30 parts of prepared rehmannia roots, 5-25 parts of wooly datchmanspipe herbs, 10-30 parts of coix seeds, 5-20 parts of morinda roots, 5-20 parts of herbs of variegate ladyslipper, 5-25 parts of glassy ganoderma, 5-20 parts of burdock, 5-20 parts of ephedra herbs, 10-30 parts of European verbena herbs, 5-20 parts of loose knots, 5-20 parts of siegesbeckia herbs and 5-15 parts of liquorice roots. The traditional Chinese medicine composition has effects of tonifying the liver and the kidney, nourishing the spleen, benefiting qi, dispelling the wind, removing dampness, clearing heat, removing toxins, promoting blood circulation, removing meridian obstruction, relaxing tendons and removing pain or numbness, has the significant effect on the dermatomyositis and has the reliable action.

The invention discloses a medicinal composition for treating dermatomyositis. The medicinal composition is prepared from the following main raw materials in part by weight: 100 to 200 parts of buffalo horn, 10 to 100 parts of tripterygium wilfordii, 100 to 200 parts of rehmannia root, 10 to 100 parts of rhubarb, 100 to 200 parts of sweet wormwood herb, 100 to 200 parts of red-rooted salvia root, 100 to 200 parts of suberect spatholobus stem, 100 to 200 parts of astragalus, 10 to 100 parts of epimedium herb and 10 to 100 parts of liquoric root. A preparation method for the medicinal composition comprises the following steps of: weighing the raw materials according to a formula, and uniformly mixing the raw materials by crush and water extraction and concentration or in a mode of combining the crush and the water extraction and concentration to obtain the medicinal composition. The medicinal composition can clear heat and cool blood, remove toxicity and dredge collaterals, tonify qi, strengthen the body resistance and nourish blood, and is used for fever, erythema, pain of joints and muscle, swell, laborious activity and the like caused by systemic lupus erythematosus, dermatomyositis and other rheumatism immunological diseases.

The invention provides a traditional Chinese medicine composition containing cicada shell for treating dermatomyositis and a preparation thereof. The dermatomyositis is classified as 'flaccidity syndrome' by the theory of collateral diseases of the Chinese traditional medicine, and the pathogenesis of the dermatomyositis is mainly the deficiency of the spleen and the kidney, no source for the production and transformation of qi and blood, inability of the weakened body resistance to conquer pathogen, and obstruction of the collaterals of muscles and skin by wind cold dampness, thus affecting the liver, the kidney and the spleen and causing the yin collaterals stasis of internal organs, qi-blood disharmony, and malnutrition of the limbs, skin, tendons and channels. Aiming at treating syndromes of obstruction of channels and collaterals and collateral deficiency caused by pathogen of the dermatomyositis, the traditional Chinese medicine composition determines the treatment based on differentiation of symptoms and signs by the theory of the collateral deficiency of Chinese traditional medicine, and is made from dried rehmannia root, turtle shell, white mustard seed, angelica root, astragalus root, scorpion, spatholobus stem and cicada shell to regulate the nutrient and tonify deficiency, and eliminate the pathogenic factors and activate the channels. Clinical studies prove that the traditional Chinese medicine composition can treat the dermatomyositis effectively.

The invention relates to blood poison eliminating capsules, which is prepared from the following raw materials: antelope horn, scorpio, centipede, unprepared rehmannia root, sinkiang arnebia root, glabrous greenbrier rhizome and talc powder. A preparation method of the blood poison eliminating capsules comprises the following steps of: smashing antelope horn, scorpio, centipede and a half of the glabrous greenbrier rhizome into fine powder and mixing uniformly for later use; decocting unprepared rehmannia root, sinkiang arnebia root and the remaining glabrous greenbrier rhizome respectively, extracting, combining decoction liquids, filtering and concentrating the filtrate into thick paste for later use; and mixing the thick paste with the fine powder, drying, smashing, mixing uniformly, adding the talc powder, mixing uniformly and filling into capsules. The blood poison eliminating capsules have a simple preparation process, low cost, high medicament bioavailability, high stability, remarkable curative effect and no remarkable toxic or side effect, are scientifically prepared from Chinese medicinal herbs serving as raw materials, and have the effects of cooling the blood and removing the toxic materials, are mainly used for treating blood poisons such as psoriasis, erythroderma, systemic lupus erythematosus, dermatomyositis and pemphigus at acute stages, severe dermatitis medicamentosa, and the like. A more convenient and quicker Chinese traditional treatment mode is provided for the clinical treatment of skin diseases.

The invention discloses a formula traditional Chinese medicine for treating dermatosis and belongs to the technical field of traditional Chinese medicines. The formula traditional Chinese medicine comprises an external main formula and an internal auxiliary formula, and has special effects on treating psoriasis, eczema, prurigo nodosa, amyloid lichen, pruritus cutanea, pityriasis rosea, neurodermatitis, rhagadia of hands and feet, contact dermatitis, tinea capitis, tinea manuum, tinea pedis, tinea corporis, tinea versicolor, dermatitis, urticaria, acne and folliculitis. In the traditional Chinese medicine science, the cause of sores and stubborn dermatophytosis is mixture of wind, phlegm fire, dampness and pathogenic toxins. The leading cause of all diseases is wind, trembling and dizziness are caused by lesions of the liver, liver qi is stagnated to generate phlegm fire, the liver transfers malignant infections to spleen, dampness is generated due to spleen deficiency, water is retained in the earth, spleen diseases are transferred to the kidney to cause kidney deficiency, yin and yang imbalance of the human body is caused, and wind, phlegm fire, dampness, pathogenic toxin and deficiency are caused and need to be treated. The medicine can be used in four seasons, has a relatively strong repairing effect on skin epidermis, dermis, subcutaneous tissue and the like, and has the effects of relieving itching and pain, removing necrotic tissue and promoting tissue regeneration, clearing heat and drying dampness, purging fire and removing toxin, cooling blood and removing freckles and the like.

The invention discloses a medicinal composition for treating dermatomyositis. The medicinal composition is prepared from the following main raw materials in part by weight: 100 to 200 parts of buffalo horn, 10 to 100 parts of tripterygium wilfordii, 100 to 200 parts of rehmannia root, 10 to 100 parts of rhubarb, 100 to 200 parts of sweet wormwood herb, 100 to 200 parts of red-rooted salvia root, 100 to 200 parts of suberect spatholobus stem, 100 to 200 parts of astragalus, 10 to 100 parts of epimedium herb and 10 to 100 parts of liquoric root. A preparation method for the medicinal composition comprises the following steps of: weighing the raw materials according to a formula, and uniformly mixing the raw materials by crush and water extraction and concentration or in a mode of combining the crush and the water extraction and concentration to obtain the medicinal composition. The medicinal composition can clear heat and cool blood, remove toxicity and dredge collaterals, tonify qi, strengthen the body resistance and nourish blood, and is used for fever, erythema, pain of joints and muscle, swell, laborious activity and the like caused by systemic lupus erythematosus, dermatomyositis and other rheumatism immunological diseases.

The invention provides a traditional Chinese medicine composition which contains Chinese ephedra and is used for treating dermatomyositis and a preparation thereof. The dermatomyositis is classified as 'flaccidity syndrome' by the theory of collateral diseases of the Chinese traditional medicine, and the pathogenesis of the dermatomyositis is mainly the deficiency of the spleen and the kidney, nosource for the production and transformation of qi and blood, inability of the weakened body resistance to conquer pathogen, and obstruction of the collaterals of muscles and skin by wind cold dampness, thus affecting the liver, the kidney and the spleen and causing the yin collaterals stasis of internal organs, qi-blood disharmony, and malnutrition of the limbs, skin, tendons and channels. Aiming at treating syndromes of collaterals obstruction due to cold and dampness, and dysphagia and blood stasis caused by the dermatomyositis, the traditional Chinese medicine composition determines the treatment based on differentiation of symptoms and signs by using the theory of the collateral diseases of Chinese traditional medicine, and is made from the Chinese ephedra, astragalus root, asarum, Chinese yam, preparation, white mustard seed, pangolin, leatherleaf milletia, winged euony twigs, cassia twig and garter snake to warm yang and expel cold and activate blood circulation for removing obstruction in the channels. Clinical studies prove that the traditional Chinese medicine composition can treat the dermatomyositis effectively.

The invention discloses a simple and convenient senile plaque removal plaster. The simple and convenient senile plaque removal plaster is characterized by consisting of a medical adhesive tape, an ethylene vinyl acetate copolymer (EVA) foaming layer, a salicylic acid-phenol ointment and SOD (Superoxide Dismutasen) cream, wherein the EVA foaming layer (2) is arranged on the medical adhesive tape (1); the salicylic acid-phenol ointment (3) is arranged in the middle of the EVA foaming layer (2); and the SOD cream (5) is arranged on the salicylic acid-phenol ointment (3). The senile plaque removal plaster has the technical effects that treatment medicine is fixed at a treating point of the senile plaque in the way that the EVA foaming layer is fixed through the medical adhesive tape; and through the EVA foaming layer, a hole for containing the medicine can be conveniently cut according to the size of the senile plaque, thus sealing the medicine; the salicylic acid-phenol ointment, which is used for treating the senile plaque, namely keratosis of melanocyte, is strong in penetrating power and relatively low in irritation; and the SOD cream can relieve the irritation of the salicylic acid-phenol ointment, eliminate harmful materials generated during metabolism, prevent and treat dermatomyositis and resist skin aging, thus effectively removing the senile plaque.